Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses

Journal of Inherited Metabolic Disease

Volumn 28, Issue 2, 2005, Pages 187-202

  Tomatsu, S ^a   Okamura, K ^b   Maeda, H ^b   Taketani, T ^c   Castrillon, S V ^a   Gutierrez, M A ^a,f   Nishioka, T ^a   Fachel, A A ^a   Orii, K O ^a,d   Grubb, J H ^a   Cooper, A ^e   Thornley, M ^e   Wraith, E ^d   Barrera, L A ^f   Laybauer, L S ^g   Giugliani, R ^g   Schwartz, I V ^g   Frenking, G Schulze ^h   Beck, M ^h   Kircher, S G ⁱ   Paschke, E ^j   Yamaguchi, S ^c   Ullrich, K ^k   Haskins, M ^l   Isogai, K ^d   Suzuki, Y ^d   Orii, T ^d   Kondo, N ^d   Creer, M ^a   Okuyama, T ^m   Tanaka, A ⁿ   Noguchi, A ^c   more..

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SEIKAGAKU CORPORATION   (Japan)

^c SHIMANE UNIVERSITY   (Japan)

^d GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^f PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^g FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^h JOHANNES GUTENBERG UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF VIENNA   (Austria)

^j UNIVERSITY OF GRAZ   (Austria)

^k UNIVERSITY OF HAMBURG   (Germany)

^l UNIVERSITY OF PENNSYLVANIA   (United States)

^m NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

ⁿ OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BIOLOGICAL MARKER; GLYCOSAMINOGLYCAN; KERATAN SULFATE; LYSOSOME ENZYME; N ACETYLGALACTOSAMINE 6 SULFATASE; SPHINGOLIPID;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY FLUID; CHILD; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; INFANT; LIPID BLOOD LEVEL; LIPID DEGRADATION; LIPID STORAGE; LYSOSOME; MAJOR CLINICAL STUDY; MAROTEAUX LAMY SYNDROME; MORQUIO SYNDROME; MUCOLIPIDOSIS; MUCOPOLYSACCHARIDOSIS; NEWBORN; SANFILIPPO SYNDROME; TISSUE DISTRIBUTION; URINALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; INFANT, NEWBORN; KERATAN SULFATE; MIDDLE AGED; MUCOLIPIDOSES; MUCOPOLYSACCHARIDOSES; SENSITIVITY AND SPECIFICITY;

EID: 21144434782     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10545-005-5673-3     Document Type: Article

References (27)

1. Caterson B, Christner JE, Baker JR (1983) Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan. J Biol Chem 258: 8848-8854.
2. Chai W, Luo J, Lim CK, et al (1998) Characterization of heparin oligosaccharide mixtures as ammonium salts using electrospray mass spectrometry. Anal Chem 70: 2060-2066.
3. Chang MH, Bindloss CA, Grabowski GA, et al (2000) Saposins A, B, C, and D in plasma of patients with lysosomal storage disorders. Clin Chem 46: 167-174.
4. Crawley AC, Niedzielski KH, Isaac EL, et al (1997) Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI. J Clin Invest 99: 651-662.
5. Crow J, Gibbs DA, Cozens W, et al (1983) Biochemical and histopathological studies on patients with mucopolysaccharidoses, two of whom had been treated by fibroblast transplantation. J Clin Pathol 36: 415-430.
6. de Jong JG, Wevers RA, Liebrand-van Sambeek R (1992) Measuring urinary glycosaminoglycans in the presence of protein: An improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin Chem 38: 803-807.
7. Hua CT, Hopwood JJ, Carlsson SR, et al (1998) Evaluation of the lysosome-associated membrane protein LAMP-2 as a marker for lysosomal storage disorders. Clin Chem 44: 2094-2102.
8. Kakkis ED, Muenzer J, Tiller GE, et al (2001) Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 344: 182-188.
9. Karlsson M, Edfors-Lilja I, Bjornsson S (2000) Binding and detection of glycosaminoglycans immobilized on membranes treated with cationic detergents. Anal Biochem 286: 51-58.
10. Kinoshita A, Sugahara K (1999) Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: Application to disaccharide composition analysis and exosequencing of oligosaccharides. Anal Biochem 269: 367-378.
11. Kornfeld S, Sly WS (2001) I-cell disease and pseudo-Hurler polydystrophy: Disorders of lysosomal enzyme phosphorylation and localization. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn, vol. 4. New York: McGraw-Hill, 3469-3482.
12. Leroy JG, DeMars RI (1967) The remarkable cells cultured from a human with Hurler syndrome: An approach to visual selection for in vitro genetic studies. In Vitro 2: 107-109.
13. Meikle PJ, Brooks DA, Ravenscroft EM, et al (1997) Diagnosis of lysosomal storage disorders: Evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker. Clin Chem 43: 1325-1335.
14. Meikle PJ, Hopwood JJ, Clague AE, etal (1999) Prevalence of lysosomal storage disorders. JAMA 281: 249-254.
15. Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn, vol. 4. New York: McGraw-Hill, 3421-3452.
16. Oguma T, Toyoda H, Toida T, et al (2001a) Analytical method for keratan sulfates by high-performance liquid chromatography/turbo-ionspray tandem mass spectrometry. Anal Biochem 290: 68-73.
17. Oguma T, Toyoda H, Toida T, et al (2001b) Analytical method of chondroitin/dermatan sulfates using high performance liquid chromatography/turbo ionspray ionization mass spectrometry: Application to analyses of the tumor tissue sections on glass slides. Biomed Chromatogr 15: 356-362.
18. Shinmei M, Miyauchi S, Machida A, et al (1992) Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 35: 1304-1308.
19. 1H NMR study of a fucose-containing heptasaccharide derived from a keratanase digestion of bovine articular cartilage keratan sulphate. Carbohydr Res 255: 303-309.
20. Tomatsu S, Okamura K, Taketani T, et al (2004) Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA. Pediatr Res 55: 592-597.
21. Tondeur M, Vamos-Hurwitz E, Mockel-Pohl S, et al (1971) Clinical, biochemical, and ultrastructural studies in a case of chondrodystrophy presenting the I-cell phenotype in tissue culture. J Pediatr 79: 366-378.
22. Toyoda H, Demachi Y, Komoriya S et al (1998) Characterization and determination of human urinary keratan sulfate. Chem Pharm Bull 46: 97-101.
23. Whitley CB, Spielmann RC, Herro G, et al (2002) Urinary glycosaminoglycan excretion quantified by an automated semimicro method in specimens conveniently transported from around the globe. Mol Genet Metab 75: 56-64.
24. Wiesmann UN, Spycher MA, Meier C, et al (1980) Prenatal mucopolysaccharidosis II (Hunter): A pathogenetic study. Pediatr Res 14: 749-756.
25. Wraith JE, Clarke LA, Beck M, et al (2004) Enzyme replacement therapy for mucopolysaccharidosis I: A randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 144: 581-588.
26. Yamada H, Miyauchi S, Morita M, et al (2000) Content and sulfation pattern of keratan sulfate in hip osteoarthritis using high performance liquid chromatography. J Rheumatol 27: 1721-1724.
27. Yoshida K, Miyauchi S, Kikuchi H, et al (1989) Analysis of unsaturated disaccharides from glycosaminoglycuronan by high-performance liquid chromatography. Anal Biochem 177: 327-332.